Resolvin D2 restores neutrophil directionality and improves survival after burns

Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double‐edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FASEB journal 2013-06, Vol.27 (6), p.2270-2281
Hauptverfasser: Kurihara, Tomohiro, Jones, Caroline N., Yu, Yong‐Ming, Fischman, Alan J., Watada, Susumu, Tompkins, Ronald G., Fagan, Shawn P., Irimia, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2281
container_issue 6
container_start_page 2270
container_title The FASEB journal
container_volume 27
creator Kurihara, Tomohiro
Jones, Caroline N.
Yu, Yong‐Ming
Fischman, Alan J.
Watada, Susumu
Tompkins, Ronald G.
Fagan, Shawn P.
Irimia, Daniel
description Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double‐edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from circulation protects vital organs against neutrophil‐induced damage but leaves the body exposed to infectious complications. Here we show that restoring normal neutrophil migratory phenotype in rats with burn injuries correlates with improved survival in a classical double‐injury model of sequential burn and septic insults. We uncovered that the directionality of neutrophils from burned rats can be restored both in vitro by 1 nM resolvin D2 (RvD2) and in vivo by RvD2 for 7 d, 25 ng/kg body mass (8–10 ng/rat). Restoring neutrophil directionality dramatically increases survival after a second septic insult at d 9 postburn. Survival of RvD2‐treated animals increases from 0 to 100% after lipopolysaccharide injection and is extended by 1 wk after cecal ligation. Survival does not significantly increase when the restoration of neutrophil directionality is incomplete, following shorter regimens of RvD2. We conclude that restoring neutrophil directionality using RvD2 could have prophylactic value and delay lethal complications after burn injuries.—Kurihara T., Jones, C. N., Yu, Y.‐M., Fischman, A. J., Watada, S., Tompkins, R. G., Fagan, S. P., Irimia, D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 27, 2270–2281 (2013). www.fasebj.org
doi_str_mv 10.1096/fj.12-219519
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3659356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551638500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4658-2f9bc668f0c168a94a48c5ee9d4a00c8e4a57dbd508bcbe89fa7f2783173597e3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhxhnlyIGUsR1_XZBooYBUCcTH2XKcMfXKGy92ErT_nlRbKrjAZeYwjx7NzEvIUwpnFIx8GbZnlLWMGkHNPbKhgkMrtYT7ZAPasFZKrk_Io1q3AECByofkhPGOg1F6Qz59xprTEsfmDWsK1imvpRlxnkreX8fUDLGgn2IeXYrToXHj0MTdvuRlxepclri41LgwYWn6uYz1MXkQXKr45Lafkm-Xb79evG-vPr77cPH6qvWdFLplwfReSh3AU6md6VynvUA0Q-cAvMbOCTX0gwDd-x61CU4FpjSnigujkJ-SV0fvfu53OHgcp-KS3Ze4c-Vgs4v278kYr-33vFguheFCroLnt4KSf8zr5XYXq8eU3Ih5rpYKQdfXCYD_o1yozmja3aAvjqgvudaC4W4jCvYmLxu2ljJ7zGvFn_15xR38O6AVUEfgZ0x4-KfMXn45Z8AUgASq-S99k6L1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1357498140</pqid></control><display><type>article</type><title>Resolvin D2 restores neutrophil directionality and improves survival after burns</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><creator>Kurihara, Tomohiro ; Jones, Caroline N. ; Yu, Yong‐Ming ; Fischman, Alan J. ; Watada, Susumu ; Tompkins, Ronald G. ; Fagan, Shawn P. ; Irimia, Daniel</creator><creatorcontrib>Kurihara, Tomohiro ; Jones, Caroline N. ; Yu, Yong‐Ming ; Fischman, Alan J. ; Watada, Susumu ; Tompkins, Ronald G. ; Fagan, Shawn P. ; Irimia, Daniel</creatorcontrib><description>Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double‐edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from circulation protects vital organs against neutrophil‐induced damage but leaves the body exposed to infectious complications. Here we show that restoring normal neutrophil migratory phenotype in rats with burn injuries correlates with improved survival in a classical double‐injury model of sequential burn and septic insults. We uncovered that the directionality of neutrophils from burned rats can be restored both in vitro by 1 nM resolvin D2 (RvD2) and in vivo by RvD2 for 7 d, 25 ng/kg body mass (8–10 ng/rat). Restoring neutrophil directionality dramatically increases survival after a second septic insult at d 9 postburn. Survival of RvD2‐treated animals increases from 0 to 100% after lipopolysaccharide injection and is extended by 1 wk after cecal ligation. Survival does not significantly increase when the restoration of neutrophil directionality is incomplete, following shorter regimens of RvD2. We conclude that restoring neutrophil directionality using RvD2 could have prophylactic value and delay lethal complications after burn injuries.—Kurihara T., Jones, C. N., Yu, Y.‐M., Fischman, A. J., Watada, S., Tompkins, R. G., Fagan, S. P., Irimia, D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 27, 2270–2281 (2013). www.fasebj.org</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.12-219519</identifier><identifier>PMID: 23430978</identifier><language>eng</language><publisher>Bethesda, MD, USA: Federation of American Societies for Experimental Biology</publisher><subject>Animals ; Burns - complications ; Burns - drug therapy ; Burns - physiopathology ; chemotaxis ; Chemotaxis, Leukocyte - drug effects ; Chemotaxis, Leukocyte - physiology ; Docosahexaenoic Acids - pharmacology ; Docosahexaenoic Acids - physiology ; inflammation ; innate immunity ; lipid mediators ; Male ; microfluidics ; Neutrophils - drug effects ; Neutrophils - physiology ; Rats ; Rats, Wistar ; Research Communications ; Sepsis - complications ; Sepsis - drug therapy ; Sepsis - physiopathology</subject><ispartof>The FASEB journal, 2013-06, Vol.27 (6), p.2270-2281</ispartof><rights>FASEB</rights><rights>FASEB 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4658-2f9bc668f0c168a94a48c5ee9d4a00c8e4a57dbd508bcbe89fa7f2783173597e3</citedby><cites>FETCH-LOGICAL-c4658-2f9bc668f0c168a94a48c5ee9d4a00c8e4a57dbd508bcbe89fa7f2783173597e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffj.12-219519$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffj.12-219519$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23430978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kurihara, Tomohiro</creatorcontrib><creatorcontrib>Jones, Caroline N.</creatorcontrib><creatorcontrib>Yu, Yong‐Ming</creatorcontrib><creatorcontrib>Fischman, Alan J.</creatorcontrib><creatorcontrib>Watada, Susumu</creatorcontrib><creatorcontrib>Tompkins, Ronald G.</creatorcontrib><creatorcontrib>Fagan, Shawn P.</creatorcontrib><creatorcontrib>Irimia, Daniel</creatorcontrib><title>Resolvin D2 restores neutrophil directionality and improves survival after burns</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double‐edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from circulation protects vital organs against neutrophil‐induced damage but leaves the body exposed to infectious complications. Here we show that restoring normal neutrophil migratory phenotype in rats with burn injuries correlates with improved survival in a classical double‐injury model of sequential burn and septic insults. We uncovered that the directionality of neutrophils from burned rats can be restored both in vitro by 1 nM resolvin D2 (RvD2) and in vivo by RvD2 for 7 d, 25 ng/kg body mass (8–10 ng/rat). Restoring neutrophil directionality dramatically increases survival after a second septic insult at d 9 postburn. Survival of RvD2‐treated animals increases from 0 to 100% after lipopolysaccharide injection and is extended by 1 wk after cecal ligation. Survival does not significantly increase when the restoration of neutrophil directionality is incomplete, following shorter regimens of RvD2. We conclude that restoring neutrophil directionality using RvD2 could have prophylactic value and delay lethal complications after burn injuries.—Kurihara T., Jones, C. N., Yu, Y.‐M., Fischman, A. J., Watada, S., Tompkins, R. G., Fagan, S. P., Irimia, D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 27, 2270–2281 (2013). www.fasebj.org</description><subject>Animals</subject><subject>Burns - complications</subject><subject>Burns - drug therapy</subject><subject>Burns - physiopathology</subject><subject>chemotaxis</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Chemotaxis, Leukocyte - physiology</subject><subject>Docosahexaenoic Acids - pharmacology</subject><subject>Docosahexaenoic Acids - physiology</subject><subject>inflammation</subject><subject>innate immunity</subject><subject>lipid mediators</subject><subject>Male</subject><subject>microfluidics</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - physiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Research Communications</subject><subject>Sepsis - complications</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - physiopathology</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhxhnlyIGUsR1_XZBooYBUCcTH2XKcMfXKGy92ErT_nlRbKrjAZeYwjx7NzEvIUwpnFIx8GbZnlLWMGkHNPbKhgkMrtYT7ZAPasFZKrk_Io1q3AECByofkhPGOg1F6Qz59xprTEsfmDWsK1imvpRlxnkreX8fUDLGgn2IeXYrToXHj0MTdvuRlxepclri41LgwYWn6uYz1MXkQXKr45Lafkm-Xb79evG-vPr77cPH6qvWdFLplwfReSh3AU6md6VynvUA0Q-cAvMbOCTX0gwDd-x61CU4FpjSnigujkJ-SV0fvfu53OHgcp-KS3Ze4c-Vgs4v278kYr-33vFguheFCroLnt4KSf8zr5XYXq8eU3Ih5rpYKQdfXCYD_o1yozmja3aAvjqgvudaC4W4jCvYmLxu2ljJ7zGvFn_15xR38O6AVUEfgZ0x4-KfMXn45Z8AUgASq-S99k6L1</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Kurihara, Tomohiro</creator><creator>Jones, Caroline N.</creator><creator>Yu, Yong‐Ming</creator><creator>Fischman, Alan J.</creator><creator>Watada, Susumu</creator><creator>Tompkins, Ronald G.</creator><creator>Fagan, Shawn P.</creator><creator>Irimia, Daniel</creator><general>Federation of American Societies for Experimental Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>201306</creationdate><title>Resolvin D2 restores neutrophil directionality and improves survival after burns</title><author>Kurihara, Tomohiro ; Jones, Caroline N. ; Yu, Yong‐Ming ; Fischman, Alan J. ; Watada, Susumu ; Tompkins, Ronald G. ; Fagan, Shawn P. ; Irimia, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4658-2f9bc668f0c168a94a48c5ee9d4a00c8e4a57dbd508bcbe89fa7f2783173597e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Burns - complications</topic><topic>Burns - drug therapy</topic><topic>Burns - physiopathology</topic><topic>chemotaxis</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Chemotaxis, Leukocyte - physiology</topic><topic>Docosahexaenoic Acids - pharmacology</topic><topic>Docosahexaenoic Acids - physiology</topic><topic>inflammation</topic><topic>innate immunity</topic><topic>lipid mediators</topic><topic>Male</topic><topic>microfluidics</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - physiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Research Communications</topic><topic>Sepsis - complications</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurihara, Tomohiro</creatorcontrib><creatorcontrib>Jones, Caroline N.</creatorcontrib><creatorcontrib>Yu, Yong‐Ming</creatorcontrib><creatorcontrib>Fischman, Alan J.</creatorcontrib><creatorcontrib>Watada, Susumu</creatorcontrib><creatorcontrib>Tompkins, Ronald G.</creatorcontrib><creatorcontrib>Fagan, Shawn P.</creatorcontrib><creatorcontrib>Irimia, Daniel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurihara, Tomohiro</au><au>Jones, Caroline N.</au><au>Yu, Yong‐Ming</au><au>Fischman, Alan J.</au><au>Watada, Susumu</au><au>Tompkins, Ronald G.</au><au>Fagan, Shawn P.</au><au>Irimia, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resolvin D2 restores neutrophil directionality and improves survival after burns</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2013-06</date><risdate>2013</risdate><volume>27</volume><issue>6</issue><spage>2270</spage><epage>2281</epage><pages>2270-2281</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double‐edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from circulation protects vital organs against neutrophil‐induced damage but leaves the body exposed to infectious complications. Here we show that restoring normal neutrophil migratory phenotype in rats with burn injuries correlates with improved survival in a classical double‐injury model of sequential burn and septic insults. We uncovered that the directionality of neutrophils from burned rats can be restored both in vitro by 1 nM resolvin D2 (RvD2) and in vivo by RvD2 for 7 d, 25 ng/kg body mass (8–10 ng/rat). Restoring neutrophil directionality dramatically increases survival after a second septic insult at d 9 postburn. Survival of RvD2‐treated animals increases from 0 to 100% after lipopolysaccharide injection and is extended by 1 wk after cecal ligation. Survival does not significantly increase when the restoration of neutrophil directionality is incomplete, following shorter regimens of RvD2. We conclude that restoring neutrophil directionality using RvD2 could have prophylactic value and delay lethal complications after burn injuries.—Kurihara T., Jones, C. N., Yu, Y.‐M., Fischman, A. J., Watada, S., Tompkins, R. G., Fagan, S. P., Irimia, D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 27, 2270–2281 (2013). www.fasebj.org</abstract><cop>Bethesda, MD, USA</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>23430978</pmid><doi>10.1096/fj.12-219519</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2013-06, Vol.27 (6), p.2270-2281
issn 0892-6638
1530-6860
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3659356
source MEDLINE; Wiley Online Library All Journals; Alma/SFX Local Collection
subjects Animals
Burns - complications
Burns - drug therapy
Burns - physiopathology
chemotaxis
Chemotaxis, Leukocyte - drug effects
Chemotaxis, Leukocyte - physiology
Docosahexaenoic Acids - pharmacology
Docosahexaenoic Acids - physiology
inflammation
innate immunity
lipid mediators
Male
microfluidics
Neutrophils - drug effects
Neutrophils - physiology
Rats
Rats, Wistar
Research Communications
Sepsis - complications
Sepsis - drug therapy
Sepsis - physiopathology
title Resolvin D2 restores neutrophil directionality and improves survival after burns
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resolvin%20D2%20restores%20neutrophil%20directionality%20and%20improves%20survival%20after%20burns&rft.jtitle=The%20FASEB%20journal&rft.au=Kurihara,%20Tomohiro&rft.date=2013-06&rft.volume=27&rft.issue=6&rft.spage=2270&rft.epage=2281&rft.pages=2270-2281&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.12-219519&rft_dat=%3Cproquest_pubme%3E1551638500%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1357498140&rft_id=info:pmid/23430978&rfr_iscdi=true